Progesteron receptor status as a predictor of progression-free survival and overall survival in patients with early breast cancer. Background: Obese patients experience planned or unplanned reduction ...
Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate Cancer A database of 208 patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback